About 7,000 people of Alicante could suffer drop.

-Gout is the most common inflammatory arthritis and in Alicante could now affect between 1% and 2% of the population, 85% men

– as a consequence of high levels of uric acid form of urate crystals in the joints and these can produce inflammation – gout attacks –

-diagnosis through identification of crystals is easy (e) no doubt. Gout is considered curable since normalized the levels of uric acid crystals – slowly – dissolve

-the gradual abandonment of the Mediterranean diet and the adoption of unhealthy habits as a greater intake of alcohol and obesity, are some of the factors that have increased uric acid in the blood and as a result drop cases in recent years

Alicante, 2013 February.- doctors from different parts of Spain they learned new techniques for the diagnosis of gout through identification of urate in liquid crystals articulate. Gout is a disease caused by the formation of urate crystals in joints as a result of an excess of uric acid in the blood and affects to between 1% and 2% of the population, most men (85%); about 7,000 people in Alicante could be affected by the disease.

The workshop crystals in synovial fluid analysis ”, which was held in the Hospital General Universitario de Alicante, it is one of the training courses that Menarini Spain drives inside the hood 2013: awareness of the drop of year ”. In particular, it has been taught by Prof. Eliseo Pascual Gómez, Professor of medicine and Chief of section of Rheumatology of Hospital General Universitario de Alicante and member of the study group of joint diseases crystalline of the Spanish society of Rheumatology (be).

The workshop had aimed to demonstrate that the investigation of the presence of crystals in synovial fluid allows a diagnosis no doubt facilitating immediate treatment. A new technique that is expected can be implanted in all Spanish hospitals Rheumatology services in the coming years.
According to Prof. Pascual what we try is that rheumatologists are acquainted with the detection of the crystals under a microscope, learning to differentiate the different types and achieving that the arthritis by crystals are diagnosed entry saving time and media, and providing immediate treatment ”.

Increasing numbers of drop

The gradual abandonment of the Mediterranean diet and the adoption of unhealthy habits as a higher obesity and alcohol intake, are some of the factors influencing the increase of cases of gout in recent years. This disease is the most common inflammatory arthritis in adults and it is curable, but a correct diagnosis is essential for this.

Excess uric acid in blood causes the formation of crystals of urate in the joints and causes episodes of intense pain, which often begins at the toe of the foot.

The persistence in the long run of these crystals of urate activates a process of chronic inflammation which, if untreated or treatment is not appropriate and effective, may lead to complications in the long term, such as renal and cardiovascular risks.

Menarini Spain

Menarini is an international pharmaceutical group with over 125 years of history in more than 100 countries in Europe, Asia, Africa and America. Menarini Spain is the third subsidiary in turnover of the group, with a production, from the headquarters of Badalona, from 48 million units of medicines a year and a staff of nearly 600 workers. The company, which just celebrated its 50th anniversary, is among the top 20 companies in the Spanish pharmaceutical industry.

Menarini Spain’s main line of research the development of drugs for the treatment of cardiovascular diseases, respiratory, infectious, gastrointestinal disorders, allergies, metabolism, pain, and inflammation problems. Its objective is to provide effective responses to the health and well-being and, therefore, committed to the research and development of new products with the technology and more advanced systems. Entails application of the highest standards in terms of quality in the manufacturing process, while respecting the environment at all times and being pioneers in obtaining various certifications in the industry.

Headquartered in Badalona, with an area of 12,000 m2, includes one of the six that the Group has in Europe, and the production plant, which manufactures drugs Menarini marketed in Spain but also exporting drugs to other European and American countries.